Nancy K Grote1, Wayne J Katon2, Joan E Russo2, Mary Jane Lohr1, Mary Curran1, Erin Galvin1, Kathy Carson3. 1. School of Social Work, University of Washington, Seattle, Washington. 2. Department of Psychiatry and Behavioral Sciences, University of Washington Medical School, Seattle, Washington. 3. Public Health Seattle and King County (PHSKC), Seattle, Washington.
Abstract
BACKGROUND: Both antenatal and postpartum depression have adverse, lasting effects on maternal and child well-being. Socioeconomically disadvantaged women are at increased risk for perinatal depression and have experienced difficulty accessing evidence-based depression care. The authors evaluated whether "MOMCare,"a culturally relevant, collaborative care intervention, providing a choice of brief interpersonal psychotherapy and/or antidepressants, is associated with improved quality of care and depressive outcomes compared to intensive public health Maternity Support Services (MSS-Plus). METHODS: A randomized multisite controlled trial with blinded outcome assessment was conducted in the Seattle-King County Public Health System. From January 2010 to July 2012, pregnant women were recruited who met criteria for probable major depression and/or dysthymia, English-speaking, had telephone access, and ≥18 years old. The primary outcome was depression severity at 3-, 6-, 12-, 18-month postbaseline assessments; secondary outcomes included functional improvement, PTSD severity, depression response and remission, and quality of depression care. RESULTS:All participants were on Medicaid and 27 years old on average; 58% were non-White; 71% were unmarried; and 65% had probable PTSD. From before birth to 18 months postbaseline, MOMCare (n = 83) compared to MSS-Plus participants (n = 85) attained significantly lower levels of depression severity (Wald's χ(2) = 6.09, df = 1, P = .01) and PTSD severity (Wald's χ(2) = 4.61, df = 1, P = .04), higher rates of depression remission (Wald's χ(2) = 3.67, df = 1, P = .05), and had a greater likelihood of receiving ≥4 mental health visits (Wald's χ(2) = 58.23, df = 1, P < .0001) and of adhering to antidepressants in the prior month (Wald's χ(2) = 10.00, df = 1, P < .01). CONCLUSION: Compared to MSS-Plus, MOMCare showed significant improvement in quality of care, depression severity, and remission rates from before birth to 18 months postbaseline for socioeconomically disadvantaged women. Findings suggest that evidence-based perinatal depression care can be integrated into the services of a county public health system in the United States. CLINICAL TRIAL REGISTRATION: ClinicalTrials.govNCT01045655.
RCT Entities:
BACKGROUND: Both antenatal and postpartum depression have adverse, lasting effects on maternal and child well-being. Socioeconomically disadvantaged women are at increased risk for perinatal depression and have experienced difficulty accessing evidence-based depression care. The authors evaluated whether "MOMCare,"a culturally relevant, collaborative care intervention, providing a choice of brief interpersonal psychotherapy and/or antidepressants, is associated with improved quality of care and depressive outcomes compared to intensive public health Maternity Support Services (MSS-Plus). METHODS: A randomized multisite controlled trial with blinded outcome assessment was conducted in the Seattle-King County Public Health System. From January 2010 to July 2012, pregnant women were recruited who met criteria for probable major depression and/or dysthymia, English-speaking, had telephone access, and ≥18 years old. The primary outcome was depression severity at 3-, 6-, 12-, 18-month postbaseline assessments; secondary outcomes included functional improvement, PTSD severity, depression response and remission, and quality of depression care. RESULTS: All participants were on Medicaid and 27 years old on average; 58% were non-White; 71% were unmarried; and 65% had probable PTSD. From before birth to 18 months postbaseline, MOMCare (n = 83) compared to MSS-Plus participants (n = 85) attained significantly lower levels of depression severity (Wald's χ(2) = 6.09, df = 1, P = .01) and PTSD severity (Wald's χ(2) = 4.61, df = 1, P = .04), higher rates of depression remission (Wald's χ(2) = 3.67, df = 1, P = .05), and had a greater likelihood of receiving ≥4 mental health visits (Wald's χ(2) = 58.23, df = 1, P < .0001) and of adhering to antidepressants in the prior month (Wald's χ(2) = 10.00, df = 1, P < .01). CONCLUSION: Compared to MSS-Plus, MOMCare showed significant improvement in quality of care, depression severity, and remission rates from before birth to 18 months postbaseline for socioeconomically disadvantaged women. Findings suggest that evidence-based perinatal depression care can be integrated into the services of a county public health system in the United States. CLINICAL TRIAL REGISTRATION: ClinicalTrials.govNCT01045655.
Authors: B N Gaynes; N Gavin; S Meltzer-Brody; K N Lohr; T Swinson; G Gartlehner; S Brody; W C Miller Journal: Evid Rep Technol Assess (Summ) Date: 2005-02
Authors: Mark T Hegel; Jürgen Unützer; Lingqi Tang; Patricia A Areán; Wayne Katon; Polly Hitchcock Noël; John W Williams; Elizabeth H B Lin Journal: Am J Geriatr Psychiatry Date: 2005-01 Impact factor: 4.105
Authors: Paul S Ciechanowski; Joan E Russo; Wayne J Katon; Michael Von Korff; Gregory E Simon; Elizabeth H B Lin; Evette J Ludman; Bessie A Young Journal: Med Care Date: 2006-03 Impact factor: 2.983
Authors: Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe Journal: JAMA Date: 2006-02-01 Impact factor: 56.272
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Wayne J Katon; Joan E Russo; Michael Von Korff; Elizabeth H B Lin; Evette Ludman; Paul S Ciechanowski Journal: Diabetes Care Date: 2008-03-10 Impact factor: 19.112
Authors: Nomi S Weiss-Laxer; Sara B Johnson; Sharon R Ghazarian; Lauren M Osborne; Anne W Riley Journal: Arch Womens Ment Health Date: 2019-07-11 Impact factor: 3.633
Authors: P G Grieve; W P Fifer; N P Cousy; C E Monk; R I Stark; J A Gingrich; M M Myers Journal: Clin Neurophysiol Date: 2019-09-03 Impact factor: 3.708
Authors: Tiffany A Moore Simas; Michael P Flynn; Aimee R Kroll-Desrosiers; Stephanie M Carvalho; Leonard L Levin; Kathleen Biebel; Nancy Byatt Journal: Clin Obstet Gynecol Date: 2018-09 Impact factor: 2.190
Authors: Rena A Menke; Leslie Swanson; Nora L Erickson; Greta Reglan; Stephanie Thompson; Katherine Harris Bullard; Katherine Rosenblum; Juan P Lopez; Maria Muzik Journal: Arch Womens Ment Health Date: 2018-10-01 Impact factor: 3.633